Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of G protein conformation in receptor-G protein selectivity. | Nat Chem Biol | 2023 | 36646958 | PubTator, text mining | PubMed |
| Scientific Abstracts of the 16th Congress of the European Academy of Paediatric Dentistry (EAPD), Lisbon, Portugal, June 15-18, 2022. | Eur Arch Paediatr Dent | 2023 | 36645645 | PubTator, text mining | PubMed |
| The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy. | Rev Endocr Metab Disord | 2023 | 36637675 | PubTator, text mining | PubMed |
| One half-century of advances in the evaluation and management of disorders of bone and mineral metabolism in children and adolescents. | J Pediatr Endocrinol Metab | 2023 | 36636022 | PubTator, text mining | PubMed |
| Disruption of the interaction between mutationally activated Gαq and Gβγ attenuates aberrant signaling. | J Biol Chem | 2023 | 36626984 | PubTator, text mining | PubMed |
| Occult lipomatosis of the nerve as part of macrodystrophia lipomatosa: illustrative case. | J Neurosurg Case Lessons | 2023 | 36624631 | PubTator, text mining | PubMed |
| A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma. | Br J Cancer | 2023 | 36624219 | PubTator, text mining | PubMed |
| Clinical Profile of Parathyroid Adenoma in Children and Adolescents: A Single-Center Experience. | Turk Arch Pediatr | 2023 | 36598212 | PubTator, text mining | PubMed |
| Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ-focal adhesion kinase signaling circuitry. | J Biol Chem | 2023 | 36596361 | PubTator, text mining | PubMed |
| Unusual phototransduction via cross-motif signaling from Gq to adenylyl cyclase in intrinsically photosensitive retinalganglion cells. | Proc Natl Acad Sci U S A | 2023 | 36584299 | PubTator, text mining | PubMed |
| PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma. | J Invest Dermatol | 2023 | 36566878 | PubTator, text mining | PubMed |
| Clinical utility of liquid biopsy and integrative genomic profiling in early-stage and oligometastatic cancer patients treated with radiotherapy. | Br J Cancer | 2023 | 36550207 | PubTator, text mining | PubMed |
| Methylation class oligosarcoma may encompass IDH-wildtype gliomas. | Acta Neuropathol | 2023 | 36520193 | PubTator, text mining | PubMed |
| Interactions Between Genetic Risk and Diet Influencing Risk of Incident Female Gout: Discovery and Replication Analysis of Four Prospective Cohorts. | Arthritis Rheumatol | 2023 | 36512683 | PubTator, text mining | PubMed |
| Plasma Cell-Free DNA in Uterine Cervical Cancer: Therapeutic Monitoring and Prognostic Values after Radical Radiotherapy. | Cancer Res Treat | 2023 | 36510654 | PubTator, text mining | PubMed |
| Primary mucosal melanomas of the head and neck are characterised by overexpression of the DNA mutating enzyme APOBEC3B. | Histopathology | 2023 | 36416305 | PubTator, text mining | PubMed |
| Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism. | J Endocrinol Invest | 2023 | 36334246 | PubTator, text mining | PubMed |
| The First Korean Case of VEXAS Syndrome Caused by a UBA1 Somatic Variant. | Ann Lab Med | 2023 | 36281520 | PubTator, text mining | PubMed |
| IGF1R Inhibition Enhances the Therapeutic Effects of Gq/11 Inhibition in Metastatic Uveal Melanoma Progression. | Mol Cancer Ther | 2023 | 36223548 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=25